Safety of 4-factor prothrombin complex concentrate (4F-PCC) for emergent reversal of factor Xa inhibitors
Jing Zang Tao, Elena N. Bukanova, Shamsuddin Akhtar
Journal
- ISSN / E-ISSN
- — / —
- DOI
- 10.1186/s40560-018-0303-y ↗
- Volume · Issue · Pages
- 6 · 1 · 34-34
- Publisher
- Springer International Publishing AG
- Article URL
- https://doi.org/10.1186/s40560-018-0303-y ↗
- Article details
- Unverified
Publication date (each date has its type and source)
14 Jun 2018
OpenAlex publication date · source: OpenAlex
| Type | Date | Source |
|---|---|---|
| OpenAlex publication date | 14 Jun 2018 | OpenAlex |
Keywords (as given): 4-factor prothrombin complex concentrate; factor Xa inhibitors; rivaroxaban; apixaban; edoxaban; drug reversal; thromboembolism; deep vein thrombosis; major bleeding; off-label drug use; thromboprophylaxis; intermittent pneumatic compression; subcutaneous heparin; intracranial hemorrhage; anticoagulation
HEC Status at Publication Not the journal's current status
HEC Status at PublicationNot conclusive
Historical status could not be conclusively determined.
- HEC status cannot be determined for this date: no HEC list is recorded as in effect on it.
Best available information, not a definitive status: HEC status cannot be determined for this date: no HEC list is recorded as in effect on it.
- Journal
- Journal of Intensive Care
- Publication date used
- 14 Jun 2018 (OpenAlex publication date)
- Applicable HEC period
- None recorded for this date
- Category
- —
- Recognition status
- Unknown (NO_PERIOD_FOR_DATE)
- Source
- —
- Verification status
- Not available
This is an automatically generated summary based on the information available on the publication date. Terms & conditions apply.